UNH at a glance
UnitedHealth Group (UNH, SEC CIK 731766) filed its latest 10-K annual report on March 2, 2026, a 10-Q quarterly report on August 10, 2026, an 8-K current report on September 8, 2026 and Form 4 insider filings as recently as October 5, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), UnitedHealth Group (UNH) reported revenue of $447.6 billion (up 11.8% from FY2024) and net income of $12.1 billion. Diluted EPS was $13.23.
- As of June 30, 2026, 66 institutional investment managers tracked by SignalX reported holding UnitedHealth Group (UNH) shares worth $155.4 billion in 13F-HR filings.
- In the last 90 days, UNH insiders reported 0 open-market purchases ($0) and 2 open-market sales ($661K) on Form 4, a net sale of $661K.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $447.6B
- +11.8% vs prior year
- Insiders · 90 days
- 0 buys · 2 sells
- Net −$661K
- 13F holders
- 66 funds
- $155.4B · +2 vs prior quarter
- Latest 8-K
- Sep 8, 2026
- Item 7.01
AI 10-K Annual Report Analysis
Latest 10-K, fiscal year ended Dec 31, 2025
Business Overview
- Dual-segment model: UnitedHealthcare (health benefits) + Optum (health services/tech), serving payers, providers, patients, and governments
- Major leadership overhaul: new CEO (Hemsley, May 2025), CFO (DeVeydt, Sept 2025), UHC CEO (Noel, Jan 2025), and Optum CEO (Conway, May 2025); near-complete C-suite reset
- CMS premium revenue = 44% of total consolidated revenues, dominated by UnitedHealthcare Medicare & Retirement's 8.4M Medicare Advantage members
- Optum Rx managed $188B in pharmaceutical spending in 2025, including ~$87B in specialty pharma, across ~64,000 retail pharmacies
- Optum Insight backlog declined to $31.1B from $32.8B YoY; Jan 2026 realignment moved Optum Financial (~26M accounts, $27B AUM) from Optum Health into Optum Insight
Management Discussion & Analysis
- Revenue $447.6B, up 12% YoY ($47.3B increase); UnitedHealthcare +16% to $344.9B; Optum +7% to $270.6B
- Operating margin collapsed to 4.2% vs 8.1% prior year; MCR deteriorated to 89.1% vs 85.5%; net earnings margin 2.7% vs 3.6%
- Best segment: Optum Rx revenue +$21.5B to $154.7B, operating margin 4.6% vs 4.4%; worst: Optum Health swung to -0.3% operating margin from +7.4%, losing $278M vs earning $7.8B
- Operating cash flow $19.7B vs $24.2B; capex $3.6B; dividends $7.9B; buybacks $5.5B vs $9.0B prior year
- Management expects Medicare Advantage and Medicaid membership contraction in 2026; 2027 Medicare Advantage rate notice "far below" medical cost trend; $2.5B restructuring charge signals significant ongoing cost pressure
Risk Factors
- Change Healthcare cyberattack (2024) exposed protected health information/PII; recently acquired non-integrated systems flagged as heightened ongoing vulnerability
- Goodwill and intangible assets $131B = 42% of total consolidated assets; impairment risk if acquired businesses underperform assumptions
- Medicare Advantage benchmark cuts by CMS ongoing; star ratings below 4 stars disqualify plans from quality bonus payments affecting benefits competitiveness
- FTC/DOJ antitrust enforcement actions previously brought against UHG; explicitly cited as barrier to completing future strategic acquisitions
- Premium revenues from risk-based products ~80% of total consolidated revenues; small utilization rate variances cause material financial swings
AI summary of the UNH 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- Four reportable segments: Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare
Risk Factors
- No material changes to risk factors since the 2025 10-K
- Carried-forward business, financial-condition, and future-results risks remain potentially material
- Additional unknown or currently immaterial risks may adversely affect results
- Share repurchases reduced authorization to 10.6 million shares by June 30, 2026
AI summary of the UNH 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 7.01: Regulation FD Disclosure
- Filing contains only signature certification dated September 8, 2026
- No substantive Regulation FD disclosure or investor-impacting information included
Item 2.02: Results of Operations and Financial Condition
- Second-quarter 2026 results announced July 16, 2026
- Exhibit 99.1 contains the earnings press release and financial results
Item 5.07: Submission of Matters to a Vote of Security Holders
- All nine director nominees elected to one-year terms, with support ranging from 89.68% to 98.96% of votes
- Executive compensation approved with 82.74% support, signaling meaningful but non-controlling shareholder opposition
AI summaries of UNH 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for UNH
Don't miss the next UNH filing
- Alerts as it files. A push when UNH files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut UNH, by share count.
- Ask anything. An AI agent that reads every UNH filing and answers with sources.
UNH alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Baker Charles D. | A | Oct 1, 2026 | 257 | - |
| Gil Kristen | A | Oct 1, 2026 | 240 | - |
| GARCIA PAUL R | A | Oct 1, 2026 | 155 | - |
| FLYNN TIMOTHY PATRICK | A | Oct 1, 2026 | 262 | - |
| MONTGOMERY RICE VALERIE MD | A | Oct 1, 2026 | 257 | - |
| Gottlieb Scott | A | Oct 1, 2026 | 257 | - |
| MCNABB FREDERICK WILLIAM III | A | Oct 1, 2026 | 291 | - |
| Noseworthy John H | A | Oct 1, 2026 | 240 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $400.3B | $447.6B |
| Operating Income | $32.4B | $32.3B | $19.0B |
| Net Income | $22.4B | $14.4B | $12.1B |
| Op. Margin | - | 8.1% | 4.2% |
| Net Margin | - | 3.6% | 2.7% |
| Balance Sheet | |||
| Total Assets | - | $298.3B | $309.6B |
| Equity | - | $98.3B | $100.1B |
| ROE | - | 14.7% | 12.0% |
| Per Share | |||
| EPS | - | $15.51 | $13.23 |
| Cash Flow | |||
| Operating CF | $29.1B | $24.2B | $19.7B |
| CapEx | $3.4B | $3.5B | $3.6B |
Source: XBRL data in UnitedHealth Group (UNH)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate UNH share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 66 | $155.40B |
| Q1 2026 | 64 | $94.72B |
| Q4 2025 | 66 | $124.75B |
| Q3 2025 | 67 | $137.18B |
| Q2 2025 | 68 | $120.12B |
| Q1 2025 | 64 | $153.10B |
| Q4 2024 | 63 | $116.50B |
| Q3 2024 | 55 | $63.36B |
- FMR LLC (Fidelity)+15.97M (+133%)
- BlackRock+3.40M (+5%)
- Franklin Resources+2.97M (+52%)
- T. Rowe Price Group+2.28M (+11%)
- JPMorgan Chase & Co+1.14M (+6%)
- Bank of America Corp−1.98M (-17%)
- Two Sigma Investments−1.50M (-88%)
- Goldman Sachs Group−863.0K (-11%)
- Renaissance Technologies LLC−791.4K (-68%)
- D.E. Shaw & Co−673.5K (-58%)
Source: 13F-HR filings on SEC EDGAR (aggregated from 513 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
UNH filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-K annual reports
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Oct 5, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 4 | Sep 24, 2026 | - | - | - |
| 8-K | Sep 8, 2026 | - | Analysis | - |
| 4 | Sep 4, 2026 | - | - | - |
Related Health Care companies
- ALHC · Alignment Healthcare, Inc.Hospital & Medical Service Plans
- CNC · Centene CorporationHospital & Medical Service Plans
- CI · CignaHospital & Medical Service Plans
- CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DEHospital & Medical Service Plans
- ELV · Elevance HealthHospital & Medical Service Plans
- HUM · HumanaHospital & Medical Service Plans
- MOH · Molina HealthcareHospital & Medical Service Plans
- OSCR · Oscar Health, Inc.Hospital & Medical Service Plans
UNH SEC filings: frequently asked questions
Are UNH insiders buying or selling?
In the last 90 days, UnitedHealth Group (UNH) officers, directors and 10% owners reported no open-market purchases and 2 open-market sales worth $660,910 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold UNH stock?
As of June 30, 2026, the largest UnitedHealth Group (UNH) holders among the 13F filers tracked by SignalX were BlackRock ($31.9 billion), Vanguard Capital Management LLC ($24.7 billion), State Street Corp ($19.0 billion), FMR LLC (Fidelity) ($11.6 billion), Vanguard Portfolio Management LLC ($10.2 billion). 13F-HR reports are filed up to 45 days after each quarter ends.
What was UNH's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), UnitedHealth Group (UNH) reported revenue of $447.6 billion (up 11.8% from FY2024) and net income of $12.1 billion. Diluted EPS was $13.23. The figures come from the XBRL data in the 10-K.
What are the main risks in UNH's latest 10-K?
In the 10-K filed March 2, 2026, UnitedHealth Group (UNH) flagged: Change Healthcare cyberattack (2024) exposed protected health information/PII; recently acquired non-integrated systems flagged as heightened ongoing vulnerability. Goodwill and intangible assets $131B = 42% of total consolidated assets; impairment risk if acquired businesses underperform assumptions. (AI summary of the Risk Factors section.)
What did UNH report in its latest 8-K?
UnitedHealth Group (UNH) filed an 8-K on September 8, 2026 reporting Item 7.01 (Regulation FD Disclosure). Filing contains only signature certification dated September 8, 2026.
What are the latest UNH SEC filings?
UnitedHealth Group (UNH) filed its latest 10-K annual report on March 2, 2026, a 10-Q quarterly report on August 10, 2026, an 8-K current report on September 8, 2026 and a Form 4 insider filing on October 5, 2026.
What is UNH's SEC CIK number?
UnitedHealth Group (UNH)'s SEC Central Index Key (CIK) is 731766. EDGAR lists every UNH filing under that number.
Ask anything about UNH
The research agent reads UNH's filings, financials, insider trades and 13F holders, then answers with sources.